Recursion Pharmaceuticals, Inc. RXRX Intangible Purchases
Intangible Purchases at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s intangible purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s intangible purchases?
- Recursion Pharmaceuticals, Inc. (RXRX) reported intangible purchases of $80K in Q1 2026.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s intangible purchases?
- Over 2 years (2022 to 2024), Recursion Pharmaceuticals, Inc.'s intangible purchases has grown at a 234.2% compound annual growth rate (CAGR), from $300K to $3.35M.
- What does intangible purchases mean?
- Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.